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S U M M A R Y
Objectives: Although herpes simplex virus (HSV)-1 and HSV-2 may co-exist and interact, some
epidemiologic features including geographical distribution, secular trends, route of transmission, and
established risk factors may distinguish these HSV sub-types.With recent data indicating a link between
genital herpes and either strain, a re-evaluation of risk factors for HSV-1/HSV-2 infection and co-
infection is needed.
Methods: Weused the 1999–2004 National Health and Nutrition Examination Study (NHANES) data and
logistic regression modeling to identify socio-demographic and behavioral risk factors that can
independently predict HSV-1/HSV-2 infection and co-infection.
Results: Approximately 48% were positive for HSV-1 alone, 7% were positive for HSV-2 alone and 12%
were co-infectedwith HSV-1 and HSV-2. History of genital herpes was found in individuals infectedwith
either or both HSV sub-types. Whereas age, sex, race, and level of education independently predicted all
three outcomes, lifetime sexual activity as well as use of tobacco products and recreational drugs mainly
correlated with HSV-2 infection and HSV-1/HSV-2 co-infection. Lifetime use of alcohol was not
consistently associated with HSV-1/HSV-2 infection and co-infection.
Conclusions: Sexual activity played an important role for HSV-2 and was potentially important for HSV-
1, with implications for healthcare practice and vaccine development.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Nearly eight distinct herpesviruses are known to cause
infectious diseases in human populations.1,2 This Herpesviridae
group includes herpes simplex viruses (HSV), varicella zoster virus,
cytomegalovirus, Epstein–Barr virus, and Kaposi’s sarcoma-asso-
ciated viruses.1,3 Believed to be prevalent in 60–95% of human
adults, HSV infection is frequently asymptomatic and exists as two
main sub-types, HSV-1 and HSV-2, both of which have been linked
with signiﬁcant disability and healthcare costs.1,4 HSV infection
can also be fatal, especially in neonates and immune suppressed
persons.1,4 Once acquired, HSV infections are lifelong non-curable
conditions, with periods of latency and recurrence.1,4 Spread of an
HSV infection occurs as a result of symptomatic or asymptomatic
reactivation, which can be either spontaneous or triggered by
external stimuli.1,4 In the absence of effective vaccination, various§ Presented in part at the 42nd Annual Society for Epidemiology Research
Meeting, Anaheim, California, USA, June 23–26, 2009.
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doi:10.1016/j.ijid.2009.12.007treatments are currently used to alleviate symptoms and reduce
the likelihood of horizontal and vertical transmission.1 Because it is
not a reportable disease, reliable data on HSV prevalence is
inconsistently available worldwide. Yet, it has been established
that patterns of HSV-1/HSV-2 infection and co-infection vary by
geographic region and by ‘high-risk’ status for acquiring sexually
transmitted diseases (STDs).5,6 In the USA, it is estimated that 40–
63% of people are seropositive for HSV-1, whereas 16–18% are
seropositive for HSV-2,1,2 ranking above European countries and
below sub-Saharan Africa.4,7 Since high-risk groups for either or
both HSV sub-types need to be identiﬁed prior to public health
intervention, the epidemiology of co-infection with HSV-1 and
HSV-2 is of particular interest. Whether or not infection with one
HSV type can protect against the other or reduce clinical
manifestations of the other remains subject to debate.1,4 Overall
evidence suggests that antibodies against one type of HSV (e.g.,
HSV-1) provide cross-immunity, ameliorating the severity, dura-
tion, and frequency of a subsequent infection by the other serotype
(e.g., HSV-2).1
Despite the fact that HSV-1 and HSV-2 may co-exist and
interact, many epidemiologic features distinguish these two viral
sub-types. First, HSV-1 infection has been primarily linked withses. Published by Elsevier Ltd. All rights reserved.
H.A. Beydoun et al. / International Journal of Infectious Diseases 14S (2010) e154–e160 e155non-genital diseases.1 By contrast, HSV-2 is thought to be the agent
responsible for genital herpes.1 Greater attention has been paid to
HSV-2 than to HSV-1 due to its putative role in facilitating the
acquisition, progression and spread of HIV.1,4,8–11 Recent informa-
tion indicates that both HSV-1 and HSV-2 can be linked to genital
herpes.1,4 In fact, an increasing number of genital herpes cases are
being attributed to HSV-1 rather than HSV-2 exposure.4 Dimin-
ished exposure to HSV-1 during childhood and risky sexual
behaviors that promote the transmission of HSV-1 through the
oral–genital route may be responsible for this ﬁnding.1,4 Second,
secular trends indicate that HSV-2 seroprevalence is on the rise in
many developed and developing countries, whereas HSV-1
seroprevalence has not changed substantially over time.1,4 Third,
HSV-1 and HSV-2 share some of their established risk factors. HSV-
1 seroprevalence is inﬂuenced by age, race, geographical region,
and socioeconomic status, whereas HSV-2 seroprevalence is
affected by age, sex, race, socioeconomic status, STD history, age
at ﬁrst intercourse, and number of lifetime sexual partners.1
Due to recent changes in the epidemiology of HSV-1 and HSV-2,
a renewed investigation of personal characteristics that may
distinguish HSV-1 and HSV-2 infections and co-infections is
warranted. Both modiﬁable and non-modiﬁable risk factors need
to be examined to inform policy-makers in efforts to reduce the
burden of HSV infection and its associated health problems. In the
current study we used a nationally representative sample to
identify socio-demographic and behavioral risk factors associated
with HSV-1 infection alone, HSV-2 infection alone, and co-
infection with HSV-1 and HSV-2 among adults aged 18–49 years
in the USA. We speciﬁcally hypothesized that risk factors for one
HSV strain will differ among those who are co-infected with the
other HSV strain compared to those who are not.
2. Methods
2.1. Data source
We analyzed existing data from the National Health and
Nutrition Examination Study (NHANES). Conducted by the
National Center for Health Statistics (NCHS) and the Centers for
Disease Control and Prevention (CDC), NHANES is a series of cross-
sectional surveys originally designed for the evaluation of health
and nutritional characteristics of the civilian population of the USA.
All NHANES surveys use a stratiﬁed, multistage probability cluster
sampling design. Demographic, socioeconomic, and health data
were collected by trained staff using household interviews. In
addition, a mobile examination center run by health professionals
collected numerous measurements including anthropometric,
blood pressure, and laboratory tests, either on all or a sub-group
of study participants. Detailed descriptions of the NHANES study
design and data collection procedures have been published
elsewhere.12,13 Since 1999, NHANES has become a continuous
surveillance system. We therefore combined the 1999–2000,
2001–2002, and 2003–2004 NHANES datasets for the current
analyses. The study was approved by the Eastern Virginia Medical
School Institutional Review Board.
2.2. Measures – HSV-1 and HSV-2
The 1999–2004 NHANES surveys include laboratory data for
several STDs. The current analyses were focused on HSV-1 and
HSV-2 infection and co-infection among adults aged 18–49 years.
In NHANES, sera were tested for antibodies against HSV-1 and
HSV-2.5 Monoclonal antibodies and afﬁnity chromatography were
used to purify viral glycoproteins speciﬁc to HSV-1 (designated gG-
1) and HSV-2 (designated gG-2) and provide antigens for type-
speciﬁc herpes serology assays.5 Antibodies reactive to thoseantigens were detected using a highly sensitive test capable of
discriminating between HSV-1 and HSV-2,5 namely the solid-
phase enzymatic immunodot assay.14 One caveat to the immu-
noassay is that it lacks sensitivity for early HSV-1 infection.14 HSV-
2 seropositivity was further conﬁrmed by a gG-2 monoclonal
antibody inhibition assay.5 The primary outcome of interest was
HSV-1/HSV-2 infection and co-infection deﬁned as ‘HSV-1 alone’,
‘HSV-2 alone’, ‘both HSV-1 and HSV-2’ or ‘neither HSV-1 nor HSV-
2’; the latter group was selected as reference. Self-reported history
of genital herpes and other STDs was also evaluated through
interviewdata. It is worth noting that no enquiriesweremadewith
regard to presence of vesicles, ulcers, or non-speciﬁc symptoms
such as itching or burning. Rather, participants were asked ‘Has a
doctor or other healthcare professional ever told you that you had
genital herpes?’
2.3. Socio-demographic and risk behavioral factors
Data on demographic, socioeconomic, and tobacco use char-
acteristics were ascertained for all survey participants through
computer-assisted personal interviews (CAPI).15 Sexual behaviors
and alcohol and recreational drug use were evaluated in different
age groups applying distinct methodologies. For instance, alcohol
usewas assessed for individuals 20 years and older through CAPI.15
Recreational drug use and sexual behaviors were assessed using an
audio computer-assisted personal self-interview (ACASI) ques-
tionnaire for individuals in the age range of 12–59 years and 14–59
years, respectively.16–18
2.4. Statistical analysis
Descriptive, bivariate, and multivariate analyses were con-
ducted using STATA version 8. Two-sided statistical tests were
performed at an alpha level of 0.05. Using survey commands, we
applied recommended sub-sample weights for the period of
1999–2004. Mobile examination center (MEC) exam weights
were used for all analyses. Masked variance units were used to
estimate variances through a Taylor series linearization method.
Crude and adjusted odds ratios (COR and AOR) and their 95%
conﬁdence intervals (CI) were computed, taking sampling
weights into consideration. These weights were deﬁned to
represent the US civilian, non-institutionalized population while
accounting for over-sampling of certain age and ethnic groups and
interview non-response.2 Bivariate associations were analyzed
using Pearson’s Chi-square test for independence. Initially, we
evaluated the relationship of HSV-1/HSV-2 infection and co-
infection with selected socio-demographic characteristics,
namely sex, age group, race, and education. Then, we examined
whether lifetime use of tobacco products (cigarettes, cigars, pipes,
snuff, chew), alcohol, and recreational drugs, as well as sexual
activity, correlated with HSV-1/HSV-2 infection and co-infection,
after adjustment for age and sex. Sexual activity was deﬁned in
terms of lifetime experience with and age at initiation of vaginal,
oral, or anal sex; data on speciﬁc sexual practices such as oral sex
or number of simultaneous sexual partners were not available.
Finally, a multinomial logistic regression model for correlates of
HSV-1/HSV-2 infection and co-infection was created. The model
included socio-demographic (age, sex, race, education) and
behavioral (lifetime experiences with tobacco, alcohol, recrea-
tional drugs and sexual intercourse) characteristics that were
plausibly linked to either or both HSV strains. In this model, the
dependent variable was deﬁned as four categories, namely ‘non-
infected (reference group)’, ‘HSV-1 infected alone’, ‘HSV-2
infected alone’ and ‘HSV-1 and HSV-2 co-infected’; two-way
interaction terms were evaluated for statistical signiﬁcance
within the multinomial model.
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3.1. HSV-1/HSV-2 infection and co-infection
In the 1999–2004 NHANES, laboratory tests used to measure
HSV-1 and HSV-2 seroprevalence were performed on a total of
8277 survey participants aged 18–49 years. Furthermore, 5850
subjects had interview data on past diagnosis with genital herpes.
Unweighted analyses suggested the following: of 204 participants
with self-reported genital herpes, 21.6% tested positive for HSV-1
alone, 34.8% tested positive for HSV-2 alone, and 39.2% were co-
infected with HSV-1 and HSV-2; Of 5646 participants with no self-
reported genital herpes, 52.9% tested positive for HSV-1 alone, 6.4%
tested positive for HSV-2 alone, and 14.6% were co-infected with
HSV-1 and HSV-2. Further analyses indicated that the mean age of
participants who tested positive for HSV-1 alone and had a history
of genital herpes was 35.9 ( 6.9) years; their mean age at initiation
of sexual activity was 16.6 ( 2.4) years. Neither their current age nor
their age at initiation of sexual activity was signiﬁcantly different
from that of participants who tested positive for HSV-2 alone and
reported a history of genital herpes; however, the distribution by race
was signiﬁcantly different among these two groups (p < 0.0001), with
a greater percentage of non-Hispanic whites in the former than in the
latter group. Taking sampling weights into consideration, it was
estimated that 48.4% of the study population was positive for HSV-1
alone, 7.4% was positive for HSV-2 alone, and 11.8% was co-infected
with HSV-1 and HSV-2; the remaining 32.4% was infected with
neither HSV-1 nor HSV-2, and chosen as the reference group. Figure 1
presents the percentage of seronegative individuals according to sex
and age group; this subset is susceptible to either HSV strain and
would therefore beneﬁt from vaccine development. HSV-1/HSV-2
susceptibility appeared to decline steadily between 18 and 39 years of
age (ptrend < 0.0001); furthermore, males were consistently more
susceptible to HSV-1/HSV-2 acquisition than females regardless of
age (p < 0.0001).
3.2. Socio-demographic factors
Prevalence rates of HSV-1/HSV-2 infection and co-infection by
socio-demographic characteristics are presented in Table 1.Figure 1. Percent of population seronegative for bFemales had more than twice the odds of being infected with
HSV-2 alone (COR 2.4, 95% CI 1.9, 2.9) or of being co-infected with
HSV-1 and HSV-2 (COR 2.8, 95% CI 2.4, 3.3) compared to males. A
consistently increasing trend by age was noted for HSV-1/HSV-2
co-infection. By contrast, the steady increase in HSV-2 infection
alone was noted until the age of 40 years and no clear trend by age
was noted for HSV-1 infection alone. Compared to non-Hispanic
whites, non-Hispanic blacks were at elevated odds of being
infected with HSV-1 alone, HSV-2 alone, or of being co-infected
with HSV-1 and HSV-2. By contrast, Hispanics were more likely
than non-Hispanic whites to be infected with HSV-1 alone or to be
co-infected with HSV-1 and HSV-2. Individuals who achieved high
school education or better were less likely than those who
achieved less than a high school education to be infectedwithHSV-
1 alone, HSV-2 alone, or both.
3.3. Risk behavioral factors
Table 2 presents associations of HSV-1/HSV-2 infection and co-
infection with lifetime use of tobacco, alcohol, and recreational
drugs, as well as sexual activity, after controlling for age and sex.
Having ever used any tobacco product, deﬁned as cigarette, cigar,
pipe, snuff or chewable tobacco, was positively correlated with all
three outcomes. Participants who had ever smoked tobacco were
more likely tobe infectedwithHSV-1alone (AOR1.2, 95%CI1.0, 1.4),
HSV-2 alone (AOR 1.9, 95% CI 1.4, 2.6), or both (AOR 2.0, 95% CI 1.6,
2.6). Lifetime use of alcohol was associated with a higher chance of
HSV-2 infection alone (AOR1.8, 95%CI 1.0, 3.2), butwas unrelated to
HSV-1 infection alone or HSV-1/HSV-2 co-infection. Similarly, the
odds of infectionwithHSV-2 alone and co-infectionwithHSV-1 and
HSV-2 were nearly twice as high among users versus non-users of
recreationaldrugs. Compared to sexually non-active individuals, the
likelihoods of HSV-1 infection alone, HSV-2 infection alone, and
HSV-1/HSV-2 co-infection were consistently increased for those
who initiated sexual activity prior to 13 years of age.
3.4. Risk factors for HSV-1/HSV-2 infection and co-infection
A multinomial logistic model for correlates of HSV-1/HSV-2
infection and co-infection is displayed in Table 3. None of the two-oth HSV-1 and HSV-2 by age group and sex.
Table 1
Infection and co-infection with herpes simplex virus-1 and 2 by socio-demographic characteristics, USA, 1999–2004
Total Not infected with HSV-1 or HSV-2 HSV-1 alone HSV-2 alone HSV-1 and HSV-2
na nb COR (95% CI) nc COR (95% CI) nd COR (95% CI)
Sex
Male 3852 1239 2087 1.0 176 1.0 350 1.0
Female 4425 1130 2196 1.1 (1.0, 1.3) 349 2.4 (1.9, 2.9) 750 2.8 (2.4, 3.3)
Age group (years)
<20 1472 664 745 1.0 34 1.0 29 1.0
20–24 1282 448 694 1.9 (1.5, 2.3) 62 3.1 (1.9, 4.8) 78 4.3 (2.8, 6.7)
25–29 1137 366 585 1.9 (1.5, 2.3) 75 4.8 (2.9, 7.9) 111 9.5 (6.0, 14.9)
30–34 1138 289 599 2.4 (1.9, 3.1) 86 7.7 (4.9, 12.1) 164 17.9 (11.0, 29.4)
35–39 1089 221 573 3.3 (2.5, 4.2) 90 11.5 (6.9, 19.3) 205 32.5 (21.0, 50.4)
40–44 1157 219 595 2.8 (2.1, 3.6) 92 9.4 (6.4, 13.8) 251 28.9 (18.9, 44.2)
45–49 1002 170 483 3.2 (2.4, 4.3) 86 13.3 (8.4, 21.2) 263 41.3 (25.9, 65.8)
Race
Non-Hispanic white 3457 1467 1524 1.0 230 1.0 236 1.0
Non-Hispanic black 1878 365 769 1.9 (1.6, 2.4) 231 4.6 (3.5, 5.9) 513 10.4 (7.7, 14.0)
Hispanic 2277 384 1611 4.3 (3.4, 5.5) 38 0.8 (0.5, 1.3) 244 4.0 (2.9, 5.5)
Other race 665 161 370 2.2 (1.7, 2.8) 26 0.9 (0.6, 1.4) 108 3.7 (2.3, 5.8)
Education 0
Less than high school 2504 452 1507 1.0 113 1.0 432 1.0
High school 2145 631 1125 0.5 (0.4, 0.7) 121 0.7 (0.5, 1.1) 268 0.3 (0.3, 0.5)
Greater than high school 3622 1294 1637 0.4 (0.3, 0.5) 290 0.7 (0.5, 1.0) 401 0.2 (0.2, 0.3)
COR, crude odds ratios (estimated taking sampling design into consideration); CI, conﬁdence intervals (estimated taking sampling design into consideration).
a n represents the non-weighted number of individuals who were infected with neither HSV-1 nor HSV-2 (reference group).
b n represents the non-weighted number of individuals infected with HSV-1 alone.
c n represents the non-weighted number of individuals infected with HSV-2 alone.
d n represents the non-weighted number of individuals infected with both HSV-1 and HSV-2.
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to be statistically signiﬁcant. After adjustment, age, female sex,
black non-Hispanic race, level of education, and having ever used
tobacco products were clearly important predictors of HSV-1
infection alone, HSV-2 infection alone, and HSV-1/HSV-2 co-
infection. While alcohol use indicators were not signiﬁcantly
related to the outcomes of interest, HSV-2 infection alone andHSV-
1/HSV-2 co-infection were nearly twice as high among users of
recreational drugs. Whereas sexually active individuals were
substantially more likely than their counterparts to be infected
with HSV-2 alone, lifetime experience with vaginal, oral, or anal
sex was also associated with a signiﬁcantly increased odds of HSV-
1 infection alone and HSV-1/HSV-2 co-infection. Broadly speaking,
risk factors for HSV-1 infection were found to be different amongTable 2
Infection and co-infection with herpes simplex virus-1 and 2 by behavioral character
Total Not infected with HSV-1 or HSV-2 HSV-
na nb
Tobacco use
Never 3506 935 1882
Ever 3258 763 1624
Alcohol use
Never 810 182 467
Ever 5414 1407 2772
Recreational drug use
Never 4807 1253 2602
Ever 1340 315 601
Sexual activity
Never 288 87 165
Initiated <13 years 317 52 146
Initiated 13 years 5542 1431 2892
Note: Odds ratio for each behavioral characteristic was adjusted for the socio-demogra
AOR, adjusted odds ratios (estimated taking sampling design into consideration); CI, c
a n represents the non-weighted number of individuals who were infected with neit
b n represents the non-weighted number of individuals infected with HSV-1 alone.
c n represents the non-weighted number of individuals infected with HSV-2 alone.
d n represents the non-weighted number of individuals infected with both HSV-1 anindividuals who were co-infected with HSV-2 compared to those
who were not; by contrast, risk factors for HSV-2 infection were
mostly similar among individuals whowere co-infected with HSV-
1 compared to those who were not.
4. Discussion
Consistentwith past research,we estimated that the prevalence
of HSV-1 was considerably higher than that of HSV-2. Our results
indicate that HSV-1 infection is prevalent in 60% while HSV-2
infection is prevalent in 19% of NHANES adults 18–49 years of age.
These rates are of the same order ofmagnitude as those reported in
other industrialized countries.19 In a recent study, Pebody et al.
described the seroepidemiology of HSV-1 and HSV-2 in eightistics, USA, 1999–2004
1 alone HSV-2 alone HSV-1 and HSV-2
AOR (95% CI) nc AOR (95% CI) nd AOR (95% CI)
1.0 221 1.0 468 1.0
1.2 (1.0, 1.4) 269 1.9 (1.4, 2.6) 602 2.0 (1.6, 2.6)
1.0 41 1.0 120 1.0
0.8 (0.6, 1.0) 405 1.8 (1.0, 3.2) 830 1.1 (0.7, 1.8)
1.0 295 1.0 657 1.0
0.9 (0.8, 1.1) 143 2.5 (1.8, 3.3) 281 1.9 (1.5, 2.5)
1.0 5 1.0 31 1.0
1.5 (0.9, 2.3) 30 4.5 (1.9, 10.3) 89 3.3 (1.5, 7.1)
1.1 (0.8, 1.4) 404 1.9 (0.9, 3.8) 815 1.2 (0.6, 2.3)
phic variables sex and age (years).
onﬁdence intervals (estimated taking sampling design into consideration).
her HSV-1 nor HSV-2 (reference group).
d HSV-2.
Table 3
Multinomial logistic model for socio-demographic and behavioral correlates of
infection and co-infection with herpes simplex virus type-1 and 2, USA, 1999–
2004
HSV-1 alonea HSV-2 alonea HSV-1 and HSV-2a
AOR (95% CI) AOR (95% CI) AOR (95% CI)
Sex
Male 1.0 1.0 1.0
Female 1.3 (1.1, 1.4) 3.0 (2.3, 4.0) 4.6 (3.6, 5.9)
Age (years) 1.0 (1.0, 1.0) 1.7 (1.0, 1.1) 1.1 (1.1, 1.1)
Race
Non-Hispanic white 1.0 1.0 1.0
Non-Hispanic black 1.9 (1.5, 2.5) 6.2 (4.5, 8.4) 14.3 (9.9, 20.7)
Hispanic 4.2 (3.2, 5.4) 1.3 (0.8, 2.2) 4.7 (3.2, 6.9)
Other race 2.8 (2.1, 3.7) 1.6 (1.0, 2.6) 5.9 (3.6, 9.9)
Education
Less than high school 1.0 1.0 1.0
High school 0.6 (0.5, 0.8) 0.6 (0.3, 0.9) 0.3 (0.2, 0.5)
More than high school 0.4 (0.3, 0.5) 0.6 (0.4, 0.9) 0.2 (0.2, 0.3)
Tobacco use
Ever 1.0 1.0 1.0
Never 1.2 (1.0, 1.5) 1.5 (1.0, 2.2) 2.1 (1.5, 2.8)
Alcohol use
Ever 0.8 (0.6, 0.9) 1.2 (0.7, 2.1) 1.0 (0.7, 1.5)
Never 1.0 1.0 1.0
Recreational drug use
Ever 0.9 (0.8, 1.1) 2.2 (1.6, 3.1) 1.9 (1.4, 2.5)
Never 1.0 1.0 1.0
Sexual activity
Initiated <13 years 1.9 (1.0, 3.3) 7.3 (1.7, 31.3) 3.4 (1.6, 7.4)
Initiated 13 years 1.7 (1.1, 2.6) 6.8 (1.9, 24.1) 2.2 (1.3, 3.7)
Never 1.0 1.0 1.0
Note: Odds ratio for each socio-demographic or behavioral characteristic was
adjusted for all other variables in the model.
AOR, adjusted odds ratio; CI, conﬁdence intervals.
a The reference group consists of individuals who were infected with neither
HSV-1 nor HSV-2.
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ranged from 52% in Finland to 84% in Bulgaria. Among individuals
12 years and older, age-standardizedHSV-2 seroprevalence ranged
from 4% in England and Wales to 24% in Bulgaria.20 Our study is
among few to have used nationally representative data in an
attempt to identify high-risk groups for HSV-1/HSV-2 infection and
co-infection2,21 and the ﬁrst to construct a multinomial logistic
model for socio-demographic and behavioral correlates of infec-
tion with HSV-1 alone, HSV-2 alone, and HSV-1/HSV-2 co-
infection.
In a systematic review, evidence for HSV-1 and HSV-2 as
causative agents of oro-labial and genital diseases was examined.4
While HSV-1 was mostly correlated with oro-labial disease
acquired during childhood, genital disease occurred following
sexual debut and was mainly attributed to HSV-2.4 Nevertheless,
HSV-2 was still capable of causing oro-labial herpes and HSV-1 of
causing genital herpes.4 The authors suggested that reduced
childhood exposure and immunity to HSV-1 and increased oro-
genital contact may have resulted in more genital herpes being
associated with HSV-1.4 Although the speciﬁc etiology cannot be
determined, our analyses indicate that either HSV-1 or HSV-2 can
be the agent responsible for genital herpes. Of 204 participants
with a history of genital herpes, 21.6% tested positive for HSV-1
alone, 34.8% tested positive for HSV-2 alone, and 39.2% were co-
infected with HSV-1 and HSV-2. The symptoms for genital herpes
are non-speciﬁc; it is, therefore, possible that individualswhowere
seronegative for HSV-2 and seropositive for HSV-1 reported
genitourinary disease associated with HSV-1 although alternative
causes such as other STDs and early HSV-2 infection could not beexcluded. Since HSV-1 prevalence was almost three times higher
than that of HSV-2, it is not surprising that a relatively large
proportion (11.8%) was co-infected with HSV-1 and HSV-2.
However, given the cross-sectional design, it is not possible to
ascertainwhich of these viral sub-typeswas ﬁrst to invade the host
or cause genital herpes. Since such infections often go unrecog-
nized, incident cases of HSV-1 or HSV-2 are not easily detected.
Therefore, socio-demographic and behavioral characteristics
associated with HSV-1, HSV-2, or both infections are merely
correlates rather than true risk factors. Nevertheless, it is worth
noting that HSV-1 was often the only etiologic agent for self-
reported genital herpes. Speciﬁcally, 21.6% of genital herpes was
associated with HSV-1 alone. Because HSV-2-associated genital
ulceration or dense inﬁltration of immune cells into the genital
tract during symptomatic and asymptomatic shedding can
facilitate the acquisition, transmission, and progression of HIV,
further studies are needed to evaluate whether the same
relationship exists between genital HSV-1 and HIV infections. In
the meantime, health education and preventive efforts through
application of screening tests should be aimed at both HSV sub-
types. On the other hand, individuals who were co-infected with
HSV-1 and HSV-2 had similar overall characteristics to individuals
infected with only HSV-2. Thus, risky sexual behaviors may be the
driving force behind HSV-2 infection and HSV-1/HSV-2 co-
infection.
In a previous study, Xu et al.2 used 1988–1994 and 1999–2004
NHANES data to assess secular trends in HSV-1 and HSV-2 in the
population of the USA. Xu et al.2 indicated that despite recent
declines in HSV-1/HSV-2 prevalence rates, HSV-1 (but not HSV-2)
seropositive individuals had a greater proportion of self-reported
genital herpes in 1999–2004 than in 1988–1994 (1.8% vs. 0.4%;
p < 0.001). These results imply that the incidence of genital herpes
caused by HSV-1 may be increasing.2 Although genital herpes has
been associated with either HSV-1 or HSV-2, few studies have
simultaneously analyzed correlates of these two viral sub-types.
Most of the current evidence comes from ‘high-risk’ populations,
including pregnant and non-pregnant women,22–25 homosexual
men,26 commercial sex workers,10,27,28 and STD clinic29 and
substance abuse30,31 patients. Since many of these studies relied
on convenience sampling, estimated rates of HSV-1/HSV-2
infection and co-infection may have been subject to self-selection
bias.
Our study ﬁndings suggest distinct etiologies for HSV sub-types,
although HSV-1 and HSV-2 may co-exist and share socio-
demographic and behavioral risk factors. The nearly two-fold
increased odds of HSV-2 infection among females reinforces the
idea that sexual activity plays a key role and that females are more
vulnerable than males to acquiring this infection through the
genital route. The lack of trend by age implies that environmental
exposures during childhood may be more salient than later
exposures for the acquisition of HSV-1 infection. Speciﬁcally, HSV-
1 infection could be attributed to poor hygienic conditions during
childhood, eventually leading to non-genital forms of herpes.1
Acquisition of HSV-1 during childhoodmay protect, in part, against
later acquisition of HSV-2 or reduce the likelihood of clinical
manifestations associatedwith HSV-2 infection.1 Nevertheless, the
steady increase with age of HSV-1/HSV-2 co-infection is expected
as it is consistent with cumulative exposure to either strain over
time. A cohort effect may also be operating whereby older
individuals were more likely to have been infected with HSV-1
during childhood than their younger counterparts. Disparities by
race1,5,32 and level of education1 are reminiscent of socio-cultural
factors, namely poverty and patterns of sexual activity, as
important risk factors for acquiring either type of HSV infection.
While socioeconomic conditions may help explain elevated HSV-1
infection rates among Hispanics, both socioeconomic and beha-
H.A. Beydoun et al. / International Journal of Infectious Diseases 14S (2010) e154–e160 e159vioral risk factors might be playing a role in the high HSV-1 and/or
HSV-2 infection rates of non-Hispanic blacks. Tobacco smoking,1,33
recreational drug use,34,35 and multiple sexual partners1,36 are risk
behaviors that have been previously linked with numerous STDs,
including HSV-2. Our results suggest that HSV-2 infection and
HSV-1/HSV-2 co-infection are consistently inﬂuenced by these
behaviors, most of which are characteristic of low socioeconomic
conditions. Interestingly, lifetime use of alcohol was not consis-
tently related to HSV-1/HSV-2 infection and co-infection. This
result is not aligned with studies of STDs and alcohol use
disorders.31,37,38 It is plausible that, unlike the use of tobacco
and recreational drugs, which are clearly addictive behaviors
affecting mainly sensation seekers,39,40 identifying a role for
alcohol use in STDs depends on how it is deﬁned and measured. A
recent systematic review implied that the overall evidence for an
effect of alcohol consumption on STD acquisition remains
equivocal due to methodological differences among existing
studies.41 Instruments that measure event-speciﬁc alcohol use
or alcohol abuse and dependence rather than usual patterns of
consumption, may be better able to discriminate individuals at
high risk for acquiring HSV and other STDs. Alternatively, the lack
of association between alcohol consumption and HSV infection
may be the result of confounding by other measured and
unmeasured factors.
Our results should be interpreted with caution. First, given the
cross-sectional design, a temporal relationship between risky
behaviors and HSV-1/HSV-2 infection cannot be established. For
the same reason, we cannot ascertain the sequence of events
leading to genital herpes. Second, measurement error is an issue
especially for self-reported demographic, socioeconomic, and risk
behavioral characteristics. Since HSV-2 is clearly acquired through
sexual activity, the fact that some of those who tested positive for
HSV-2 reported themselves as abstainers raises concerns about the
validity of questionnaire items and/or HSV-2 testing. It is worth
noting that more advanced and commercially available methods
for detecting HSV-1/HSV-2 infection such as the University of
WashingtonWestern blot assay and Focus Technologies tests have
emerged since the NHANES datawere collected. Third, we relied on
existing data and were, therefore, unable to include reﬁned
exposure measurements.
In conclusion, HSV-1 infection appears to be predominantly
inﬂuenced by low socioeconomic status and may be acquired at
any time through various routes, genital or otherwise. Conversely,
HSV-2 seropositivity was associated with sexual behavior, tobacco
use and recreational drugs, in addition to demographic cofactors.
The data show a more than two-fold increased association
between sexual risk behavior and HSV-2 seropositivity, consistent
with previous studies supporting the sexual transmission of HSV-
2. Furthermore, genital herpesmay be the outcome of either HSV-1
or HSV-2 infection. In the absence of effective vaccination, risk
factors should be used to target speciﬁc sub-populations with
health education and screening interventions, in an effort to
prevent transmission to other individuals, including sex partners
and offspring. Since both HSV sub-types are linked with genital
herpes and associated health problems, continued efforts at
vaccine development should be expanded to include both HSV-1
and HSV-2 sub-types.
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